Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Three UHN research projects are being acknowledged as being "high impact" for their potential to contribute to improving the response to COVID-19.
These projects are being funded through the $8.4-million Toronto COVID-19 Action Fund, from the University of Toronto. The initiative has supported a total of 31 projects for their ability to address the pandemic and get results within a year.
As described below, these research projects will explore new insights into disease, test new treatments and help support the well-being of front-line medical workers.
The Ontario COVID-19 Prospective Cohort Study
Angela Cheung and Margaret Herridge, Senior Scientists at UHN's Toronto General Hospital Research Institute (TGHRI) and Professors of Medicine at University of Toronto
Project description: A large-scale study that brings together more than 25 researchers from other institutions to conduct five complementary projects. These projects will reveal how treatment approaches, patient genetics, sociodemographics and clinical risk factors affect outcomes of the disease. Data will be collected in the short and longer term from patients and their caregivers – up to one year after patients are released from the hospital. The findings will enable the researchers to identify those who are at increased risk for severe symptoms and long-term health effects. The findings will also help to inform large-scale public health planning, clinical care, and ongoing resource needs required to combat the virus.
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis
Jordan Feld, Senior Scientist at UHN's TGHRI, and Associate Professor of Medicine at the University of Toronto
Project description: A clinical trial that will test whether a drug – known as peginterferon lambda – affects the ability of individuals with mild to moderate COVID-19 to clear the virus. The drug acts in the body by promoting the immune system's antiviral response. It has been shown to be safe for use in humans, and has been used to treat other viral diseases, such as hepatitis C and B. If successful, the drug could help to shorten the time during which individuals are infected, therefore helping to limit spread of the virus. While the trial will initially focus on patients that are well enough to recover at home, in the future it could be expanded to test the ability of the drug to prevent disease progression in those with severe symptoms.
Mental Health Outcomes in Healthcare Workers during COVID-19
Rima Styra, Affiliate Scientist at UHN's TGHRI and Associate Professor at the University of Toronto
Project description: A study to explore the effects of the COVID-19 pandemic on front-line healthcare workers. Specifically, it will look at the factors that place these workers at risk for negative impacts on psychological wellness, morale and ability to cope. By shedding light on how the current pandemic is affecting healthcare workers, this study will enable the healthcare community to develop targeted support to those who need it the most.
"We are excited to partner with the University of Toronto on this timely initiative," says Dr. Wouters, UHN's EVP of Science and Research. "These projects illustrate the breadth of UHN experts–researchers and clinicians– that are working together to address this global pandemic."